436 results on '"Govindarajan, Sugantha"'
Search Results
2. Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure
3. Do Type and Duration of Antiretroviral Therapy Attenuate Liver Fibrosis in HIV-Hepatitis C Virus-Coinfected Patients?
4. Figure S3 from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
5. Data from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
6. The p7 Polypeptide of Hepatitis C Virus Is Critical for Infectivity and Contains Functionally Important Genotype-Specific Sequences
7. Viral and Immunological Determinants of Hepatitis C Virus Clearance, Persistence, and Disease
8. Mutations That Permit Efficient Replication of Hepatitis C Virus RNA in Huh-7 Cells Prevent Productive Replication in Chimpanzees
9. Hepatitis C Virus Lacking the Hypervariable Region 1 of the Second Envelope Protein Is Infectious and Causes Acute Resolving or Persistent Infection in Chimpanzees
10. Data from Prediagnostic Levels of Serum One-Carbon Metabolites and Risk of Hepatocellular Carcinoma
11. Supplementary Tables from Prediagnostic Levels of Serum One-Carbon Metabolites and Risk of Hepatocellular Carcinoma
12. Diminished viral replication and compartmentalization of hepatitis C virus in hepatocellular carcinoma tissue
13. Liver biopsy and histopathological diagnosis
14. Liver Biopsy and Histopathological Diagnosis
15. Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study
16. Liver Biopsy and Histopathological Diagnosis
17. B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus—associated acute liver failure
18. Challenge Pools of Hepatitis C Virus Genotypes 1-6 Prototype Strains: Replication Fitness and Pathogenicity in Chimpanzees and Human Liver-Chimeric Mouse Models
19. Toll-Like Receptor 4 Mediates Synergism between Alcohol and HCV in Hepatic Oncogenesis Involving Stem Cell Marker Nanog
20. Systematic transcriptome analysis reveals elevated expression of alcohol-metabolizing genes in NAFLD livers
21. Liver Fibrosis Progression Is Related to CD4 Cell Depletion in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus
22. Prospective Evaluation of Infection with Hepatitis G Virus in Relation to Hepatocellular Carcinoma in Shanghai, China
23. Experimental Transmission of Hepatitis C Virus-Associated Fulminant Hepatitis to a Chimpanzee
24. Successful Passive and Active Immunization of Cynomolgus Monkeys Against Hepatitis E
25. Low Frequency of p53 Mutations Observed in a Diverse Collection of Primary Hepatocellular Carcinomas
26. Lack of Protective Immunity Against Reinfection with Hepatitis C Virus
27. Experimental Infection of Chimpanzees with Hepatitis C Virus of Genotype 5a: Genetic Analysis of the Virus and Generation of a Standardized Challenge Pool
28. Experimental Infection of Chimpanzees with Hepatitis G Virus and Genetic Analysis of the Virus
29. Hepatitis E virus in rats, Los Angeles, California, USA
30. A Simian Strain of Hepatitis A Virus, AGM-27, Functions as an Attenuated Vaccine for Chimpanzees
31. Do type and duration of antiretroviral therapy attenuate liver fibrosis in HIV-hepatitis C virus-coinfected patients?
32. Aromatase (CYP19) promoter gene polymorphism and risk of nonviral hepatitis-related hepatocellular carcinoma
33. Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans
34. Histologic Outcomes in Hepatitis C–Infected Patients with Varying Degrees of Virologic Response to Interferon-Based Treatments
35. Metabolic Syndrome and Spinal Cord Injury: A 17-Year Longitudinal Study
36. Prognostic Value of Ishak Fibrosis Stage: Findings From the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
37. Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks
38. Immunity Against the GBV-B Hepatitis Virus in Tamarins Can Prevent Productive Infection Following Rechallenge and Is Long-Lived
39. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma
40. HCV core expression in hepatocytes protects against autoimmune liver injury and promotes liver regeneration in mice
41. More Advanced Hepatic Fibrosis in Hispanics with Chronic Hepatitis C Infection: Role of Patient Demographics, Hepatic Necroinflammation, and Steatosis
42. Suppression of adenoviral gene expression in the liver: role of innate vs adaptive immunity and their cell lysis mechanisms
43. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease
44. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association
45. Hepatitis C virus-associated fulminant hepatic failure
46. A double-blinded, randomized trial of hydrocortisone in acute hepatic failure
47. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S
48. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization
49. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine
50. Chronic infection with hepatitis G virus in relation to hepatocellular carcinoma among non-Asians in Los Angeles County, California
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.